TNIK and idiopathic pulmonary fibrosis: We recently identified TNIK as a crucial pro-fibrotic factor and developed INS018_055 (Rentosertib), a selective, potent TNIK inhibitor, which exhibited strong anti-fibrotic effects in murine IPF, skin fibrosis, and kidney fibrosis models [32].